HIV-1 incidence among opiate users in northern Thailand

American Journal of Epidemiology

Volumn 149, Issue 6, 1999, Pages 558-564

  Celentano, David D ^a   Hodge, Matthew J ^b   Razak, Myat Htoo ^a   Beyrer, Chris ^a   Kawichai, Surinda ^a   Cegielski, J Peter ^a   Nelson, Kenrad E ^a   Jittiwutikarn, Jaroon ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Drug utilization; Ethnic groups; HIV 1; Incidence

Indexed keywords

DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL GEOGRAPHY;

ADULT; ARTICLE; COHORT ANALYSIS; DETOXIFICATION; DRUG USE; EMPLOYMENT; ETHNOLOGY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INGESTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; SMOKING HABIT; THAILAND;

THAILAND;

EID: 0033559675     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009852     Document Type: Article

References (43)

1. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991;5 (Suppl. 2):S71-S85.
2. Suwanakool S, Rojanapithayakorn W. HIV infections in Thailand. J Med Assoc Thai 1989;72 (Suppl. 2):49-53.
3. Phanuphak P, Poshyachinda V, Uneklabh T, et al. HIV transmission among intravenous drug abusers. Program and Abstracts of the Fifth International Conference on AIDS. Montreal, Canada, June 1989. (Abstract TG025).
4. Vanichsenti S, Wright N, Akarasewi P, et al. Case-control study of HIV positivity among male intravenous drug addicts (IVDA) in Bangkok. Program and Abstracts of the Fifth International Conference on AIDS. Montreal, Canada, June 1989. (Abstract WGP19).
5. Des Jarlais DC, Choopanya K, Wenston J, et al. Risk reduction and stabilization of HIV seroprevalence among drug injectors in New York City and Bangkok, Thailand. Program and Abstracts of the Seventh International Conference on AIDS. Florence, Italy, June 1991. (Abstract MC1).
6. Freirichs RR, Ungchusak K, Htoon MT, et al. HIV sentinel surveillance in Thailand - an example for developing countries. Asia Pac J Public Health 1995;8:20-6.
7. Visudhimark A. HIV infection among hill tribal drug dependents in northern drug dependence treatment center. In: Abstracts, International Congress on AIDS, December 17-21, 1990. Bangkok, Thailand: Chulabhorn Research Institute, 1990:128.
8. Des Jarlais DC, Choopanya K, Vanichseni S, et al. AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. Am J Public Health 1994;84:452-5.
9. Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991;5:1509-13.
10. Kitayaporn D, Uneklabh C, Weniger BG, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994;8:1443-1500.
11. Brown T, Sittitrai W, Vanichseni S, Thisyakorn U. The recent epidemiology of HIV and AIDS in Thailand. AIDS 1994;8 (Suppl. 2):S131-41.
12. Mastro TD, Kitayaporn D, Weniger BG, et al. Estimating the number of HIV-infected injection drug users in Bangkok: a capture-recapture method. Am J Public Health 1994; 84:1094-9.
13. Lewis P, Lewis E. Peoples of the Golden Triangle. London, England: Thames and Hudson, 1984.
14. Feller W. An introduction to probability theory and its applications. Vol. 1. 3rd ed. New York, NY: John Wiley & Sons, 1968.
15. Selvin S. Statistical analysis of epidemiologic data. New York, NY: Oxford University Press, 1991.
16. Beyrer C, Celentano DD, Suprasert S, et al.. Widely varying HIV prevalence and risk behaviours among the ethnic minority peoples of upper northern Thailand. AIDS Care 1997; 9:427-39.
17. Celentano DD, Jittiwutikorn J, Hodge MJ, et al. The epidemiology of HIV-1 infection among opiate users in northern Thailand. J Acquir Immun Defic Syndr Hum Retrovirol 1998;17:73-8.
18. Celentano DD, Nelson KE, Suprasert S, et al. Risk factors for HIV-1 seroconversions among young men in northern Thailand. JAMA 1996;275:122-7.
19. Sirisopana N, Torugsa K, Mason CJ, et al. Correlates of HIV-1 seropositivity among young men in Thailand. J Acquir Immun Defic Syndr Hum Retrovirol 1996;11:492-8.
20. Nicolosi A, Leite MLC, Musicco M, et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. Am J Epidemiol 1992;135:225-33.
21. Pezzotti P, Phillips AN, Dorrucci M, et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of serconversion. BMJ 1996;313:583-6.
22. Moss AR, Vranizan K, Gorter R, et al. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 1994;8:223-31.
23. Rezza G, Nicolosi A, Zaccarelli M, et al. Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach. J Acqir Immun Defic Syndr 1994;7:500-3.
24. Nelson KE, Vlahov D, Galai N, et al. Incident human immunodeficiency virus (HIV) infection in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retrovir 1994;10(Suppl. 2):S243-6.
25. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland. Arch Intern Med 1995;155:1305-11.
26. Marmor H, Wolfe H, Des Jarlais DC, et al. Feasibility of future HIV vaccine trials in New York City injecting drug users (IDUs) and their sexual partners. Program and Abstracts of the Ninth International Conference on AIDS. Berlin, June 1993. (Abstract PO-C15-2962).
27. Vlahov D. HIV seroconversion studies among intravenous drug users. (Editorial). AIDS 1994;8:263-5.
28. van Haastrecht HJA, van den Hoek JAR, Bardoux C, et al. The course of the HIV epidemic among intravenous drug users in Amsterdam, the Netherlands. Am J Public Health 1991; 81:59-62.
29. Titi F, Lazzarin A, Costigliola P, et al. Human immunodeficiency virus (HIV) seropositivity in intravenous (IV) drug abusers in three cities of Italy: possible natural history of HIV infection in IV drug addicts in Italy. J Med Virol 1987;34:241-8.
30. Kalish ML, Baldwin A, Raktham S, et al. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV-1 vaccine trials. AIDS 1995;9:851-7.
31. Ou CY, Takebe Y, Weniger GB. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993;341:1171-4.
32. Weniger BG, Takebe Y, Ou C-Y, et al. The molecular epidemiology of HIV in Asia. AIDS 1994;8 (Suppl. 2):S13-S28.
33. Nelson KE, Suriyanon V, Taylor E, et al. The incidence of HIV-1 infections in village populations of northern Thailand. AIDS 1994;8:951-5.
34. Carr JK, Sirisopana N, Torugsa K, et al. Incidence of HIV-1 infection among young men in Thailand. J Acquir Immun Defic Syndr 1994;7:1270-5.
35. Nelson KE, Celentano DD, Eiumtrakul S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996;335:297-303.
36. Nelson KE, Celentano DD, Suprasert S, et al. Risk factors for HIV infection among young adult males in northern Thailand. JAMA 1993;270:955-60.
37. Celentano DD, Nelson KE, Suprasert S, et al. Dynamics of risk behaviors for HIV infection among young Thai men. J Acquir Immun Defic Syndr Hum Retrovirol 1995;10:477-83.
38. Brettle RP. HIV and harm reduction for injection drug users. (Editorial). AIDS 1991;5:125-36.
39. Normand J, Vlahov D, Moses LE. Preventing HIV transmission. The role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
40. Nelson KE, Vlahov D, Cohn S, et al. Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA 1991;266:2259-61.
41. Des Jarlais DC, Paone D, Friedman SR, et al. Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health 1995;85:1577-84.
42. Metzger D, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immun Defic Syndr 1993;6:1049-56.
43. Vanichseni S, Wongsuwn B, BMA Narcotics Clinic no. 6 staff, et al. A controlled trial of methadone maintenance in a population of intravenous drug users in Bangkok: implications for prevention of HIV. Intern J Addict 1991;26:1313-20.